Skip to content

Clinical trials

Muscular Atrophy, Spinal trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Atrophy, Spinal Country / region: China Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20162
20191
20202
20213
20224
20232
20242
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting5
Active, not recruiting5
Enrolling by invitation2
Not yet recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen7
GeneCradle Inc2
Guangzhou Jiayin Biotech Ltd2
Hoffmann-La Roche2
Novartis Pharmaceuticals2
Peking University Third Hospital2
First Affiliated Hospital of Fujian Medical University1
Lantu Biopharma1
Nikegen Pharmaceutical (Hangzhou) Company Limited1
The Children's Hospital of Zhejiang University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Atrophy, Spinal23
Muscular Atrophy2
Muscular Diseases2
Bulbo-Spinal Atrophy, X-Linked1
Endocrine System Diseases1
Spinal Muscular Atrophies of Childhood1

Trials

Showing 26 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.